AML Hub (@aml_hub) 's Twitter Profile
AML Hub

@aml_hub

A global education platform providing clinical updates on acute myeloid leukemia. #leusm
linktr.ee/AcuteMyeloidLe…

ID: 3289960226

linkhttp://www.aml-hub.com calendar_today24-07-2015 14:13:43

7,7K Tweet

8,8K Followers

2,2K Following

AML Hub (@aml_hub) 's Twitter Profile Photo
AML Hub
@aml_hub

3 months ago

CONGRESS | #ASCO25 | PRESENTATION Patricia Kropf Novant Health shares findings from a phase Ib/II study (NCT04964518) of the investigational oral BCL-2 inhibitor lisaftoclax (LISA) plus azacitidine (AZA) in patients with ND or R/R AML/MPAL, or high-risk MDS/CMML (N = 103). In the

CONGRESS | #ASCO25 | PRESENTATION Patricia Kropf <a href="/NovantHealth/">Novant Health</a> shares findings from a phase Ib/II study (NCT04964518) of the investigational oral BCL-2 inhibitor lisaftoclax (LISA) plus azacitidine (AZA) in patients with ND or R/R AML/MPAL, or high-risk MDS/CMML (N = 103). In the